Jubilant FoodWorks Faces Margin Squeeze, BPCL Sees Rebound Potential

BROKERAGE-REPORTS
Whalesbook Logo
AuthorRiya Kapoor|Published at:
Jubilant FoodWorks Faces Margin Squeeze, BPCL Sees Rebound Potential
Overview

Brokerages have differing views on Indian stocks. Goldman Sachs is neutral on Jubilant FoodWorks, citing margin issues and slow growth. Nomura recommends BPCL, expecting a recovery. Morgan Stanley is overweight on PI Industries, forecasting revenue normalization. Nuvama upgraded Grasim Industries on demand and chemical growth.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Goldman Sachs reiterated a neutral rating for Jubilant FoodWorks, lowering its price target to ₹460 from ₹480. While the company's fourth-quarter EBITDA slightly exceeded expectations, partly due to selling off Dunkin' operations, ongoing inflation in energy, labor, and raw materials is expected to reduce near-term profits. Domino's Pizza in India saw very slow same-store sales growth of 0.2% year-on-year. Lowering the free-delivery threshold led to reduced average transaction values, though management expects things to stabilize in early fiscal year 2027. Jubilant's Indian operations are projected to grow slower than industry peers in fiscal year 2027.

Sector Watch: BPCL, PI Industries, Grasim Industries

Nomura began covering Bharat Petroleum Corporation Limited (BPCL) with a buy recommendation and a ₹365 target price. The firm noted BPCL's strong fourth-quarter gross refining margins, helped by favorable oil prices and inventory gains. Nomura predicts that new projects at Hindustan Petroleum Corporation Limited (HPCL) will fuel future growth, requiring high ongoing investment. An earnings recovery for HPCL is anticipated for fiscal year 2028, after a likely weak fiscal year 2027.

Morgan Stanley maintained its overweight rating on PI Industries, with a price target of ₹3,883. The firm expects revenue growth to turn positive in fiscal year 2027, with better performance from both export and domestic agrochemical businesses. PI Industries' global biologicals division reported margins over 60%, and its pharmaceutical unit is expected to double revenue in two to three years. Analysts noted PI Industries is more cautious about the agrochemical sector's recovery than its competitors. The company received US regulatory approval for its bionematicide product and plans to launch Pioxaniliprole in India this year.

Nuvama upgraded Grasim Industries to buy from hold, raising its price target to ₹3,546 from ₹3,336. Key reasons for the upgrade include rising demand for Cellulosic Staple Fibre and improved margins in the chemical segment. The expansion of its paints division and B2B e-commerce platform are reportedly on track. Nuvama forecasts an improvement in Grasim Industries' net debt to EBITDA ratio.

Competitive Dynamics and Potential Risks

While PI Industries shows strong margins in its biologicals segment, its more reserved comments on agrochemical recovery compared to peers suggest potential market share risks if the sector recovery is slow. For Jubilant FoodWorks, projected growth lagging its peers could signal a competitive disadvantage, particularly if inflation continues to impact consumer spending and operating costs. BPCL's growth depends on the successful completion of upcoming HPCL projects, with fiscal year 2027 expected to be challenging, creating a period of vulnerability. Grasim Industries' debt reduction progress will be closely monitored as it expands its paints business, which historically requires significant capital.

Analyst Sentiment

Analyst sentiment is cautiously optimistic for the energy and diversified manufacturing sectors, balanced by concerns over consumer discretionary spending and input cost inflation affecting food services. For PI Industries, the forecast revenue recovery in fiscal year 2027 is a key factor in Morgan Stanley's positive view. Nuvama's upgrade for Grasim Industries is driven by expectations of increased demand and successful development of new ventures. Brokerages anticipate BPCL will benefit from an eventual rise in refining margins and operational efficiency gains.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.